Institute of Clinical Laboratory Diagnostics, Osijek University Hospital, Osijek, Croatia.
Faculty of Medicine, JJ Strossmayer University of Osijek, Osijek, Croatia.
Biochem Med (Zagreb). 2017 Oct 15;27(3):030801. doi: 10.11613/BM.2017.030801.
Heparin induced thrombocytopenia (HIT) is a life-threatening disorder which diagnosis depends on laboratory evaluation. The objective of this report is to present the impact of different laboratory methods for HIT detection on the diagnostic evaluation process. In this case, a 78-year old female patient previously diagnosed with monoclonal gammopathy of undetermined significance (MGUS) was administered with heparin for pulmonary embolism treatment. Patient's initial diagnostic work-up (determination of platelet count and prothrombin time measurement for monitoring of pharmacotherapy) was followed by the clinical estimation of HIT likelihood by "4Ts" score, two immunoassays (ID-PaGIA Heparin/PF4 Antibody Test and ELISA PF4 IgG assay) and one functional test called high-performance liquid chromatography serotonin release assay (HPLC-SRA). The result of "4Ts" score indicated a low likelihood of HIT but persistent thrombocytopenia that appeared days after discontinuation of heparin therapy suggested delayed-onset HIT. Both immunoassays were positive for presence of HIT-autoantibodies, while the functional HPLC-SRA was negative. Since different methods gave opposing results, their interpretation required great attention. In comparison to the HPLC-SRA, immunoassays are prone to the analytical interferences associated with the presence of non-specific antibodies, which may lead to false positive results. In this case, where the patient is known to produce antibodies of undetermined significance, HIT was ruled out as the possible cause of persistent thrombocytopenia primarily due to the negative result of HPLC-SRA, which is not prone to this type of interferences, but also due to the low "4Ts" clinical score.
肝素诱导的血小板减少症(HIT)是一种危及生命的疾病,其诊断依赖于实验室评估。本报告的目的是展示不同的 HIT 检测实验室方法对诊断评估过程的影响。在本例中,一名 78 岁女性患者,先前被诊断为意义未明的单克隆丙种球蛋白病(MGUS),因肺栓塞接受肝素治疗。患者的初始诊断检查(血小板计数和凝血酶原时间测定以监测药物治疗)后,通过“4Ts”评分、两种免疫测定(ID-PaGIA 肝素/PF4 抗体检测和 ELISA PF4 IgG 检测)和一种称为高效液相色谱法-血清素释放检测(HPLC-SRA)的功能检测来评估 HIT 的可能性。“4Ts”评分的结果表明 HIT 的可能性较低,但肝素治疗停止数天后出现持续血小板减少,提示为迟发性 HIT。两种免疫测定均为 HIT 自身抗体阳性,而功能 HPLC-SRA 为阴性。由于不同的方法得出了相反的结果,因此需要特别注意其解释。与 HPLC-SRA 相比,免疫测定易受到与非特异性抗体存在相关的分析干扰,这可能导致假阳性结果。在这种情况下,由于患者已知产生意义未明的抗体,因此 HIT 被排除为持续性血小板减少的可能原因,主要是由于 HPLC-SRA 的阴性结果,该结果不易受到这种类型的干扰,同时也由于“4Ts”临床评分较低。